No takes yet. Share an insight, caveat, or question.
Randomized trial uncovers an epithelial-immune dual phenotype in gastric cancer ascites, suggesting new predictive biomarkers for therapy response.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: